About AGENEBIO, INC.
AgeneBio is a company focused on discovering and developing innovative therapeutics for patients at risk for neurological and psychiatric conditions, with a lead late-stage clinical program targeting the prevention of Alzheimer’s dementia.
Therapeutics research and developmentClinical program developmentNeurological and psychiatric condition treatment research
Is this your company?
Claim this profile to keep it accurate — and see the federal & state opportunities GovIntel's AI has matched to AGENEBIO, INC. right now.
Claim this profile See matched opportunitiesData compiled from public government sources including SAM.gov, USAspending.gov, and state procurement records. Last verified against federal award records. Inaccurate? Let us know.